Improving consistency for a Mefenamic acid immediate release formulation

Research output: Contribution to conferencePoster

9 Downloads (Pure)


Mefenamic acid (MFA) product performance is highly dependant on particle size and can lead to variable efficacy. In this study, a structured development program was applied, developing a crystalline solid dispersion (CSD) formulation, retaining API properties and improving performance consistency compared to a commercial product.
Original languageEnglish
Number of pages1
Publication statusPublished - 22 Oct 2020
EventCMAC Annual Open Day - Virtual event, Glasgow, United Kingdom
Duration: 21 Oct 202022 Oct 2020


ConferenceCMAC Annual Open Day
Country/TerritoryUnited Kingdom


  • Mefenamic acid
  • MFA
  • rheology screening
  • hot-melt-extrusion
  • crystalline solid dispersion (CSD)


Dive into the research topics of 'Improving consistency for a Mefenamic acid immediate release formulation'. Together they form a unique fingerprint.

Cite this